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Uncaria rhynchophylla (UR), which is a traditional Chinese medicine, has anticonvulsive eﬀect in our previous studies, and the
cellular mechanisms behind this are still little known. Because of this, we wanted to determine the importance of the role of UR on
kainic acid- (KA-) induced epilepsy. Oral UR for 6 weeks can successfully attenuate the onset of epileptic seizure in animal tests.
Hippocampal mossy ﬁber sprouting dramatically decreased, while neuronal survival increased with UR treatment in hippocampal
CA1 and CA3 areas. Furthermore, oral UR for 6 weeks signiﬁcantly attenuated the overexpression of astrocyte proliferation and
S100B proteins but not γ-aminobutyric acid A (GABAA) receptors. These results indicate that oral UR for 6 weeks can successfully
attenuate mossy ﬁber sprouting, astrocyte proliferation, and S100B protein overexpression and increase neuronal survival in KA-
induced epileptic rat hippocampus
1.Introduction
Epilepsy is characterized as a condition of brain imbalance,
especially in the hippocampus, with unpredictable discharge
and seizures. In clinical studies, 30% of patients with un-
controlled seizures and using current antiepileptic drugs do
not have curative therapy. Many antiepileptic drugs act as
antiexcitatory or inhibitory agents to suppress seizure occur-
rence. These results in side eﬀects on cognition and memory
[1]. Developing more speciﬁc antiepileptic drugs that target
cellular mechanisms while maintaining normal brain func-
tion is crucial. Glutamate is one of the excitatory neurotrans-
mitters which bind to N-methyl-D-asparate (NMDA), alpha
amino-3-hydroxy-5-mehtyl-4-isoxazole (AMPA), and kainic
acid (KA) receptors to enhance neuronal activity through
sodium inﬂux. Activation of KA subtype of glutamate recep-
tors by glutamate or KA have been reported to contribute to
the epilepsy process. Recent scientiﬁc studies have indicated
that intraperitoneal (i.p.) injection of KA can successfully
induce epilepsy in both rats and mice with accompanying
phenomena similar to that in human temporal lobe epilepsy
[2].
Glutamate is one of the common excitatory neurotrans-
mittersinthemammaliancentralnervoussystem(CNS).Itis
released from presynaptic terminals and binds to glutamate
receptors [3]. Glutamate receptor activation causes a large
inﬂuxofsodiumionswhichexciteneurons.Oneofthemajor
inhibitory neurotransmitters in the CNS is γ-aminobutyric2 Evidence-Based Complementary and Alternative Medicine
acid (GABA). The GABAA receptor is one of the most
important inhibitory neurotransmitters in the brain and is
a focus of study in animal models of epilepsy [4, 5]. Ac-
tivation of GABAA receptors is used in the development of
antiepileptic drugs, including benzodiazepines, gabapentin,
and barbiturates [6, 7]. Imbalanced neuronal network dam-
age in the mammalian brain is highly associated with neu-
rological and neurodegenerative diseases such as epilepsy
[8], Parkinson’s [9], and Huntington’s disease [10]. Epilepsy
oftenoccursinpatientssuﬀeringfromrecurrentseizuresand
it is usually associated with an imbalance of excitatory and
inhibitory neurons in the CNS [11].
Epilepsy is usually associated with neuronal loss [12],
astrocyte proliferation [13], mossy ﬁber sprouting [14], and
synaptic reorganization in the hippocampus. The neuron
loss is mainly observed in the CA3, CA1, and hilus areas in
the hippocampus [15]. These alterations, especially mossy
ﬁber sprouting, are highly associated with spontaneous re-
current seizures in humans and in epileptic animal models.
The most frequent pathologic techniques to investigate axon
sprouting in epileptic animal models using Timm’s stain
[16]. Axon sprouting from dentate granular cells increases
neuronal excitability by forming numerous novel synapses
leading to seizure generation [17]. Recent studies have re-
ported that regular exercise increases the synapses in the hip-
pocampaldentategyrus(DG)toincreasememoryformation
[18]. Mice with pilocarpine-induced epilepsy had significant
mossy ﬁber sprouting in the inner molecular layer of the DG.
Animals with pilocarpine-induced epilepsy also developed
spontaneous seizures at 3 weeks after induction. However,
whether or not these phenomena are directly involved in the
epileptogenic process or are just an indirect secondary con-
sequence of excitotoxicity from recurrent seizures is unclear
[19].
Upregulation of glial ﬁbrillary acidic protein (GFAP) and
S100B protein was observed in the late phase of epileptic
animal models but not during recurrent seizure onset [20].
Recently, glial cells and astrocytes have been implicated in
pain sensation, immune response, and neural information
processing. Astrocytes have also been reported as functional
receptors as neurons and can regulate astrocyte function
[21]. Elevation of the intracellular Ca2+ concentration in
cultured astrocytes can induce glial cells to release glutamate
[22]. Glial cells and astrocytes can release neurotransmitters
to modulate neuron excitability and plasticity [23]. S100
proteins, ﬁrst isolated from the brain in 1965, are low-
molecular weight proteins that have calcium-binding prop-
erties [24]. S100B proteins are highly expressed in the CNS
to enhance neurite outgrowth [25] and stimulate astrocyte
proliferation in vitro [26]. Age-related increases in astrocytes
have been observed in the hippocampus as determined with
the astrocyte speciﬁc marker, GFAP. S100B can also increase
intracellular free calcium concentrations to regulate neuron
excitability [27]. Chronic epilepsy causes overexpression of
S100B by astrocytes from neuronal damage or dysfunction
[28].
UR, a Chinese medicinal herb, is used to decrease hy-
perfunction of the liver, dizziness, and epilepsy. UR also has
an antiepilepsy eﬀect in KA-induced seizures in rats [29].
The alkaloid fragments of UR, including rhynchophylline,
isorhynchophylline,a n disocorynoxeine, have been identiﬁed
as having a protective function that prevent neurons from
glutamate-induced cell death [30]. UR also protected neu-
rons from apoptosis and participated in neuronal protection
[31] by inhibiting c-Jun kinase phosphorylation and nuclear
factor-κB( N F - κB) activity in KA-induced epileptic rats [32].
To investigate the roles and mechanisms of oral UR
on KA-induced long-term seizures, we investigated whether
UR could ameliorate KA-induced epileptic seizures. The
alkaloid fragment of UR is known for its antiepileptic eﬀect
in clinical therapy through its ability to inhibit abnormal
recurrent discharges and further induce apoptosis. We used
animalbehaviors,immunohistochemistry,andWesternblot-
ting techniques to verify the regulatory role of UR in KA-
induced epilepsy. We next tested the expressions of NeuN,
GFAP, S100B, and GABAA in control, KA-induced, and UR-
treated groups. Overall, oral UR for 6 weeks signiﬁcantly
attenuated epileptic seizure and simultaneously increased
neuron survival. It also attenuated GFAP and S100B protein
levels but not GABAA receptors.
2.MaterialsandMethods
2.1. Animals. Male Sprague-Dawley (SD) rats weighing 200–
300g were used in this study. Rats fasted overnight with free
access to water. Usage of the animals was approved by the
Institute Animal Care and Use Committee of China Medical
University and followed the Guide for the Use of Laboratory
Animals (National Academy Press).
2.2. Extraction of UR. The UR (Rubiaceae, UR jacks) in the
present study was purchased from China and authenticated
by Chiu-Lin Tsai (director, division of Traditional Medicine
Pharmacy, China Medical University Hospital, Taiwan). The
UR was extracted by the Koda Pharmaceutical Company
(Taoyuan, Taiwan). The voucher specimen was kept in the
neuroscience laboratory room of China Medical University.
Eight kg of crude UR was extracted with 64kg of 70%
alcohol by boiling for 35min. These extracts were ﬁltered,
freeze-dried, and then stored in a drier box. The total
yield was 566.63g (7.08%). The freeze-dried extracts of
UR were qualiﬁed by a high performance liquid chroma-
tography (HPLC) system (interface D-700, Pump L-7100,
UV-Vis Detector L-7420; Hitachi Instruments Service Co.
Ltd., Ibaraki-ken, Japan) using rhynchophylline (Matsuura
Yakugyo Co. Ltd., Japan) as a standard from the Koda
Pharmaceutical Company. Each gram of freeze-dried extract
contained 1.81mg of pure alkaloid component of UR. The
dose response for this compound was reported in our
previous study [29]; hence, we used this eﬀective dose for all
e x p e r i m e n t si nt h i ss t u d y .
2.3. Establishment of Epileptic Seizure Model. These experi-
ments used 36 SD rats. Four days prior to the electroen-
cephalogram(EEG)andelectromyogram(EMG)recordings,
all rats underwent stereotactic surgery with chloral hydrate
(400mg/kg, i.p.) anesthesia. The scalp was then incised fromEvidence-Based Complementary and Alternative Medicine 3
the midline and the skull was exposed. Stainless steel screw
electrodes were implanted on the dura over the bilateral
sensorimotor cortices to serve as recording electrodes. A
reference electrode was placed in the frontal sinus. Bipolar
electrical wires were placed on the neck muscles for EMG
recordings. Electrodes were connected to an EEG and EMG-
monitoring machine (MPlOOWSW, BIOPAC System, Inc.,
Calif, USA). The epileptic seizures were conﬁrmed by behav-
ior observation (including wet dog shakes, paw tremors, and
facial myoclonia under a freely moving and conscious state),
and epileptiform discharges on EEG recordings.
The study was divided into experiment 1 and experiment
2. Each experiment included 18 rats. Each experiment was
divided into three groups of 6 rats as follows: (1) the control
group with phosphate buﬀeredsaline (PBS) i.p. only without
KA, (2) the KA group with KA at 12mg/kg i.p. only, and
(3) the UR group receiving oral UR at 1g/kg, 5days/week
continuously for 6 weeks starting the next day after KA
injection. All the rats were sacriﬁced at 6 weeks after KA
injection and the brains were removed for Timm’s stain and
for GFAP and NeuN immunohistochemistry staining (IHC)
studies in experiment 1; and for S100B and GABAA IHC
studies in experiment 2.
2.4. Timm’s Stain. The rats were perfused with 0.37%
sodium sulﬁde solution (1.17g of Na2S·9H2O, 1.19g
of NaH2PO4·H2O per 100mL) and 4% paraformalde-
hyde transcardially under anesthesia with chloral hydrate
(400mg/kg) i.p. The brain tissues were postﬁxed in 4%
paraformaldehyde. Two days prior to sectioning, the brain
tissues were immersed in a 30% sucrose solution diluted in
phosphatebuﬀersolution(PBS).Afterimmersion,thebrains
were removed from the sucrose solution and were embedded
in the tissue freezing medium at −80◦Ca n ds t o r e da t
−20◦C. The brains were cryostat-sectioned (40-μm coronal
sections for Timm’s staining and 16-μm coronal sections
for immunohistochemical staining). The 40- and 16-μm
sections were alternately processed. The 40-μms e c t i o n sw e r e
immersed in the dark in developing solution. This solution
consisted of 5.1g of citric acid, 4.7g of sodium citrate,
and 3.4g of hydroquinone dissolved in 80mL of water and
then added to 180mL of 50% Arabic gum. Then, 1mL of
17% silver nitrate solution was added to this mixture just
before the start of the developing process. The sections were
checked occasionally until proper staining was evident, then
washed in running water, dehydrated with a graded series
of ethanol solutions for 15min (75% for 5min, 95% for
5min, and ﬁnally, 99% for 5min) and xylene for 5min, and
coverslipped.
To quantify mossy ﬁber sprouting in the supragranular
molecular layer of the dentate gyrus, the staining intensity
was measured on a picture of Timm’s stained sections. Brief-
ly, stained coronal sections taken 3.64–4.10mm from the
bregma were viewed under a Zeiss microscope, and pictures
were captured by a Nikon digital camera. Utilizing image
analysis software (Image-Pro Plus, Media Cybernetics, Inc.,
Silver Spring, Md, USA), the pictures were converted to 8-
bit gray scale images. Optical density (OD) measurements
based on an average gray-scale value (0–255pixels unit) were
obtained for two parallel lines along the inner and outer
edges of the inner molecular layer (IML). A lower value
of OD corresponded to a darker image. The inner edge of
the IML is the place where aberrant mossy ﬁbers terminate,
while the outer edge of the IML was used to determine a
background value. The diﬀerence in OD between the inner
and outer edge of the IML of each section was deﬁned by
(ODo −ODi)
[ODo +OD i/2]
,( 1 )
where ODo is the OD value of the outer edge of the IML
(background value) and ODi is the OD value of the inner
edge of the IML (sprouting mossy ﬁber terminals). The
diﬀerence in OD, therefore, represents the extent of mossy
ﬁber sprouting in the IML. The greater the diﬀerence in the
OD, the higher is the density of sprouting mossy ﬁbers.
2.5. Immunohistochemistry staining. Sections were ﬁrst
washed twice (5min each) in 0.1M TRIS buﬀer (pH 7.6)
and treated with 1% H2O2 made in 0.1M TRIS buﬀer for
30min to inhibit the endogenous peroxidase activity. Then,
they were washed in 0.1M TRIS buﬀer for 5min; TRIS A,
for 10min (TRIS A: 0.1% Triton X-100 dissolved in 0.1M
TRIS buﬀer), and TRIS B, for 10min (TRIS B: 0.1% Triton
X-100 and 0.005% bovine serum albumin (BSA) in 0.1M
TRISbuﬀer).Then,the sections wereblocked in normal goat
serum (45min), washed in TRIS A and then TRIS B (10min
each), and then incubated with antibody against NeuN
(1:1000, Chemicon, USA), GFAP (1:200, CALBIOCHEM,
Germany), GABAA (1:1000, Millipore, USA), and S100B
(1:1000, Novus Biologicals, USA) overnight at 4◦C. On the
following day, sections were washed with TRIS A (10min),
then, TRIS B (10min), incubated with biotinylated goat
antirabbit immunoglobulin (Ig) G (45min), washed with
T R I SA( 1 0m i n ) ,w a s h e dw i t hT R I SD( 0 . 1 %T r i t o nX - 1 0 0
and 0.005% BSA in 0.5M TRIS buﬀer; 10min), incubated
with avidin-biotin horseradish peroxidase complex (1 hour),
washed three times with 0.1M TRIS buﬀer for 5min each,
developed in 3,3-diaminobenzidine (DAB, 1-2min), washed
three times with 0.1M TRIS buﬀer (5min each), and ﬁnally,
incubated with 0.1M TRIS buﬀer to stop the reaction.
All sections were counterstained with hematoxylin solution,
washed three times with 0.1M TRIS buﬀer, dried, and
coverslipped.
2.6. Statistical Analysis. T h ed a t aa r ep r e s e n t e da sm e a n±
SD, and a one-way ANOVA with Scheﬀe’s post hoc test was
used to examine diﬀerences between the groups. P<0.05
was considered as statistically signiﬁcant.
3. Results
3.1. Induction of Epileptic Seizures through Intraperitoneal
I n j e c t i o no fK Aa sA s s e s s e db yE E G .Epilepsy is one of the
major CNS diseases with imbalanced nerve discharge result-
ing in overexcitability in the cerebral cortex. An epileptic
animal model was used to test the eﬀect of oral UR. Ep-
ileptic seizures were induced in both the left and right4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The alteration of electroencephalographic (EEG) signals in KA-injected animals. Basal EEG activity from the sensorimotor cortex
was characterized by 6–8Hz activity in rats when awake (a). KA-induced temporal lobe seizures, including wet dog shakes (WDS) with
intermittent polyspike-like activity (b), facial myoclonia with continuous sharp waves (c) and paw tremor (PT) with continuous spike
activity (d). Lt Cx = EEG recording from the left sensorimotor cortex; Rt Cx = EEG recording from the right sensorimotor cortex; EMG =
EMG recording from the neck muscle.
cortex in 24 SD rats using a KA injection (12mg/kg, i.p.).
Three major types of seizures were induced with their
own characteristic EEG activity. Limbic motor signs, such as
wet dog shakes, paw tremor, and facial myoclonia, were
recorded in all epileptic rats. Figure 1(a) shows baseline
recordings. Wet dog shakes-induced electrical waveform
was shown by intermittent polyspike-like EEG activity
(Figure 1(b)). Facial myoclonia-induced electrical waveform
was indicated by characteristic continuous sharp EEG activ-
ity (Figure 1(c)). Paw tremor-induced electrical waveform
was deﬁned as continuous spike EEG activity (Figure 1(d)).
Electromyogram (EMG) responses were also recorded.
3.2. Long-Term Oral UR Reduced Mossy Fiber Sprouting in
KA-Induced Epileptic Rat. Mossy ﬁber sprouting accounts
for recurrent neural discharge in the hippocampus. Timm’s
staining was used to determine whether oral UR could
reverse this phenomenon in epileptic rats. The results indi-
cated that little sprouting was present in the DG molecular
layer in the PBS-injected group (Figures 2(a) and 2(b),Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Timm’s stain in hippocampal slices from PBS, KA, and UR pretreated groups. (a) whole hippocampus in PBS group (b) DG
molecular layer in PBS group (c) whole hippocampus in KA-induced group. (d) DG molecular layer in KA-induced group (e) whole
hippocampus in UR-treated group (f) DG molecular layer in UR-treated group. Timm’s staining indicated with arrows (brown). The left
panel was captured at 40x magniﬁcation while the right panel was at 400x magniﬁcation.
10.0 ± 0.8%). However, sprouting greatly increased in rats
having a KA injection (Figures 2(c) and 2(d),4 9 .8 ± 2.7%,
n = 6). This sprouting phenomenon was reduced in rats
with long-term UR administration (Figures 2(e) and 2(f),
17.3±1.1%, n = 6). KA-induced epileptic rats demonstrated
mossyﬁbersproutingandrecurrentseizures.Long-termoral
UR use successfully reduced this sprouting at 6 weeks after
KA-injection in the hippocampal DG molecular layer.
3.3. UR Improves Neuron Survival in Rat Hippocampus in
KA-Induced Epilepsy. To characterize the curative eﬀect of
UR in epileptic rats after KA injection, the neuronal marker
NeuN was employed. No signiﬁcant hippocampal neuron
loss occurred after PBS injection (Figure 3(a)) in either
the CA1 (Figure 3(b), 242.1 ± 30.3% neurons/ﬁeld), CA3
(Figure 3(c),8 9 .0 ± 7.6% neurons/ﬁeld), or Hilus regions
(Figure 3(d),9 8 .7 ± 7.8% neurons/ﬁeld). After KA injec-
tion, the hippocampal neurons were decreased using NeuN
immunohistochemistry staining (Figure 3(e)). Importantly,
the neuron loss phenomena were mainly observed in the
CA1, CA3, and the Hilus areas (Figures 3(f)–3(h),3 4 .2 ±
3.1%, 30.2 ± 6.1%, 35.3 ± 7.4% neurons/ﬁeld, n = 6, resp.).
Long-term oral UR use for 6 weeks decreased hippocampal
neuron death from i.p. KA injection (Figure 3(i)), which
mainly occurred in the CA1, CA3, and Hilus areas (Figures
3(j)–3(l), 113.5 ± 16.4%, 87.3 ± 13.4%, and 77.7 ± 9.3%
neurons/ﬁeld, compared with control group, n = 6, resp.).
These results suggest that KA i.p. might increase neuron
death in the rat hippocampus which can be reversed by long
term UR administration.
3.4. UR Attenuates Hippocampal Astrocyte Proliferation in
KA-Induced Epilepsy. Next, the roles of astrocytes in the hip-
pocampus from KA-induced epileptic rats were tested. As-
trocyte proliferation was normal in the PBS-injected group
(Figure 4(a)). They were distributed in the CA1, CA3, and6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Immunohistochemistry staining of Hematoxylin and Eosin (HE) and NeuN in hippocampal slices from PBS, KA-induced, and
UR-pretreatedgroups.HE(blue)andNeuN(brown)positivestaininginwholehippocampus(a),CA1(b),CA3(c),andHilusregionsinPBS
group. HE (blue) and NeuN (brown) positive staining in whole hippocampus (e), CA1 (f), CA3 (g), and Hilus (h) regions in KA-induced
group. HE (blue) and NeuN (brown) immunostaining in whole hippocampus (i), CA1 (j), CA3 (k), and Hilus (l) regions in UR-treated
group. The left panel was captured at 40x magniﬁcation, while the others were at 400x magniﬁcation.
Hilus areas (Figures 4(b)–4(d),2 0 .7 ± 3.2%, 15.8 ± 3.2%,
and 53.5 ± 4.3%astrocyte/ﬁeld). Astrocytes increased in
the hippocampal neurons of KA-induced rats (Figure 4(e)),
especially in the CA1, CA3, and Hilus areas (Figures 4(f)–
4(h), 112.0 ± 11.9%, 56.8 ± 7.5%, and 146.5 ± 7.4%
astrocyte/ﬁeld, P<0.01, n = 6, resp.). This phenomenon
suggested that KA-induced epilepsy was accompanied by
astrocyte proliferation. When UR was used to reduce KA-
inducedsymptoms,theresultsindicatedthattheadministra-
tion of oral UR for 6 weeks attenuated astrocyte proliferation
in the hippocampus (Figure 4(i)), especially in the CA1,
CA3, and Hilus areas (Figures 4(j)–4(l)), 58.0±7.1%, 28.3±
4.6%, and 72.3 ± 5.1%astrocyte/ﬁeld, n = 6, resp.) Serial
results implied that astrocyte proliferation increased in the
KA-induced group and that oral application of UR can
reverse this phenomenon.
3.5. UR Decreases Hippocampal S100B Protein Overexpression
in KA-Induced Epilepsy. Several studies have shown that
S100B proteins are involved in the development of epilepsy,
but the relationship between UR and S100B is unclear. Thus,
the roles of S100B proteins in KA-induced epileptic rats were
assessed. The expression of S100B proteins were commonly
distributed in the rat hippocampus (Figure 5(a)). The S100B
proteins were observed in the CA1, CA3, and Hilus areas
(Figures5(b)–5(d),33.2±6.6%,19.2±5.5%,and50.2±7.9%,
n = 6). The results indicated that KA injection can induce
the overexpression of S100B proteins (Figure 5(e)) in the
CA1,CA3,andHilusareas(Figures5(f)–5(h),121.2±11.8%,
58.8 ± 5.4%, 119.5 ± 11.8%, P<0.01, n = 6, resp.).
Further oral administration of UR signiﬁcantly reduced this
phenomenon(Figure 5(i)).Thereversepatternwasobserved
in the CA1, CA3, and Hilus areas (Figures 5(j)–5(l)), 65.3 ±
10.3%, 28.2 ±3.2%, and 61.5 ±7.2%, n = 6, resp.).
3.6. Neuroprotective Role of Oral UR is GABAA Receptor
Independent. Next, the expression of GABAA receptors was
investigated, since they have been associated with epilepsy.
Our results showed that GABAA receptors were present in
the rat hippocampus following PBS-injection (Figure 6(a)).
High magniﬁcation pictures showed that GABAA were
distributed in the CA1, CA3, and Hilus areas (Figures 6(b)–
6(d),1 0 .7 ± 2.2%, 5.8 ± 0.5%, and 4.7 ± 0.8%, n = 6). The
GABAA receptor levels did not change during KA-induced
epilepsy in the hippocampus, even in the CA1, CA3, and
Hilus areas (Figures 6(e)–6(h),9 .5 ± 3.3%, 4.8 ± 0.9%, and
3.5 ± 0.7%, P>0.05, n = 6, resp.). The GABAA receptors
were also unchanged after oral administration of UR forEvidence-Based Complementary and Alternative Medicine 7
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Figure 4:ImmunohistochemistrystainingofHEandGFAPinhippocampalslicesfromPBS,KA-induced,andUR-treatedgroups.HE(blue)
and GFAP (brown) positive staining in whole hippocampus (a), CA1 (b), CA3 (c), and Hilus (d) regions in PBS group. HE (blue) and GFAP
(brown) positive staining in whole hippocampus (e), CA1 (f), CA3 (g), and Hilus (h) regions in KA-Induced group. HE (blue) and GFAP
(brown)positivestaininginwholehippocampus(i),CA1(j),CA3(k),andHilus(l)regionsinUR-treatedgroup.Theleftpanelwascaptured
at 40x magniﬁcation, while the others were at 400x magniﬁcation.
6w e e k s( Figure 6(i)). Higher magniﬁcations of the CA1,
CA3, and Hilus areas are also presented (Figures 6(j)–6(l),
9.8 ± 2.2%, 6.7 ± 2.0%, and 7.2 ± 2.2%, n = 6, resp.).
These results suggest that long-term oral UR administration
does not alter the expression of GABAA receptors in the
hippocampus in KA and UR treated rats.
4. Discussion
Here, we used an epileptic animal model to investigate the
eﬀect of UR on KA-induced epileptic rats. Three major
types of epileptic seizures were recorded and presented, such
as wet dog shakes, paw tremors, and facial myoclonia. We
used this model to identify the curative role of UR after
6 weeks of oral administration. Our results showed that
mossy ﬁber sprouting increased in the hippocampus of rats
receiving KA injections. The phenomenon was reduced with
oral UR administration. Oral UR increased the hippocam-
pal neuron survival as shown by NeuN immunostaining.
Oral UR also decreased astrocyte proliferation and S100B
protein expression. Furthermore, oral UR did not alter the
expression of GABAA receptors. Taken together, these results
suggest that oral administration of UR has neuroprotective
eﬀect in KA-induced epileptic seizures accompanied with
increasedhippocampal neuronsurvival.Oraladministration
of UR can also attenuate mossy ﬁber sprouting, astrocyte
proliferation, and S100B protein expression but not GABAA
receptor expression.
Hippocampal mossy ﬁbers, which are the axons from
DG granule cells, innervate into dendrites of CA3 principal
cells and even inhibitory interneurons. The mossy ﬁbers
sprouting are crucial in epilepsy process in hippocampus [1].
Mossy ﬁber sprouting from recurrent synapses with other
granule cells is necessary to increase the excitability leading
to epileptic seizures. The classical pathology for both clinical
temporal lobe seizures and epileptic animal models is mossy
ﬁber sprouting in the hippocampus as demonstrated with
Timm’s staining [14]. The mossy ﬁber sprouting was always
associated with granule cell hyperexcitability, epilepsy, learn-
ing, and cognitive impairment [14]. Signiﬁcant neuronal
loss was reported in the hippocampus of epileptic animals,
including the CA3 and the hilus of the DG [33]. Our results
also suggest that oral UR administration can reduce KA-
induced epileptic seizures through attenuating mossy ﬁber
sprouting. These results suggest that oral UR administration
is a potential candidate for the clinical therapy of epilepsy
with mechanisms that operate by attenuating mossy ﬁber
sprouting.8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Immunohistochemistry staining of HE and S100B in hippocampal slices from PBS, KA-induced, and UR-treated groups. HE
(blue) and S100B (brown) positive staining in whole hippocampus (a), CA1 (b), CA3 (c), and Hilus (d) regions in PBS group. HE (blue)
and S100B (brown) positive staining in whole hippocampus (e), CA1 (f), CA3 (g), and Hilus (h) regions in KA-Induced group. HE (blue)
and S100B (brown) positive staining in whole hippocampus (i), CA1 (j), CA3 (k), and Hilus (l) regions in UR-treated group. The left panel
was captured at 40x magniﬁcation, while the others were at 400x magniﬁcation.
More and more studies have identiﬁed astrocytes as
active partners in neural information processing. Novel
techniques, such as advanced electrophysiological and Ca2+
imaging, have revealed that astrocytes have functional ion
channels and transmitter receptors like neurons [13]. In
epileptic animal models with long-term epilepsy, GFAP
immunoreactivity increased with the seizure process [20].
S100B proteins are low-molecular weight proteins which
often increase in chronic epilepsy [28], Alzheimer’s disease
[34] ,a n dh e a dt r a u m a[ 35]. S100B is highly expressed
in astrocytes in the CNS, especially in the hippocampus
[36]. S100B acts on a variety of CNS neurons to increase
calcium concentration and turn on the active phospholipase
C and IP3. The overexpression of S100B protein during the
epileptic process suggests a principle role for S100B [37].
This implies that downregulating the elevated astrocytes and
S100B has a potential in epileptic therapy. Here, we reported
that astrocytes and S100B proteins signiﬁcantly increased
during KA-induced epilepsy.
Epileptic seizures, based on excitatory and inhibitory
imbalance, can be induced by several methods. Overac-
tivation of excitatory neurotransmitter receptors, such as
by using KA injection, has been used to activate kainic
receptors which can lead to epileptic seizures [29]. Others
have reported that blocking inhibitory GABAA receptors,
such as by using pilocarpine, can also be used to successfully
induce seizures [38]. Several GABAA receptor agonists, such
as carbamazepine and gabapentin, have been used to treat
epilepticseizures.Inanimalmodels,thealterationofGABAA
r e c e p t o r si n v o l v e di ne p i l e p t i cs e i z u r e si sc o n t r o v e r s i a l .
Synaptically localized GABAA receptors were unchanged, as
indicated by the immunoreactivity of postsynaptic GABAA
receptors [39]. Vivash et al. reported that GABAA receptor
density was reduced in epilepsy rats [40]. Here, we suggest
that the use of oral UR for 6 weeks can dramatically reduce
epileptic symptoms without changing GABAA receptor den-
sity. Thus, we cannot rule out the participation of GABAA
receptors in KA-induced seizures, even if no alteration in
receptor density occurred. This result agrees with other
studies claiming that the GABAA receptor-mediated currents
were changed and not the receptor density [41]. Accordingly,
the regulation of tonic inhibition plays a more impor-
tant role in epilepsy than a general alteration of GABAA
receptors.Evidence-Based Complementary and Alternative Medicine 9
GABAA
PBS
40x
CA1
Hilus CA3
(a)
CA1
(b)
CA3
(c)
Hilus
(d)
KA
(e) (f) (g) (h)
UR
(i) (j) (k) (l)
Figure 6: Immunohistochemistry staining of HE and GABAA in hippocampal slices from PBS, KA-induced, and UR-treated groups. HE
(blue) and S100B (brown) positive staining in whole hippocampus (a), CA1 (b), CA3 (c), and Hilus (d) regions in PBS group. HE (blue)
and GABAA (brown) positive staining in whole hippocampus (e), CA1 (f), CA3 (g), and Hilus (h) regions in KA-Induced group. HE (blue)
and GABAA (brown) positive staining in whole hippocampus (i), CA1 (j), CA3 (k), and Hilus (l) regions in UR-treated group. The left panel
was captured at 40x magniﬁcation, while the others were at 400x magniﬁcation.
UR, a Chinese herb, has been used for anticonvulsive
eﬀects and the treatment of epileptic seizures. The alkaloid
component of UR is composed of rhynchophylline, isorhyn-
chophylline, corynoxeine, hirsutine,a n dhirsuteine.U Rc a n
also protect hippocampal neurons from cell death. The cell
deathandapoptosis-relatedgenessuchasc-jun,bax,andp53
were attenuated when hippocampal neurons were pretreated
with the alkaloid component of UR [32]. Our previous
study demonstrated that the alkaloid component of UR can
ameliorate KA-induced lipid peroxide in vitro and in animal
behavior, such as wet dog shakes, paw tremors, and facial
myoclonia [29].
5. Conclusions
In summary, we suggest that oral UR administration for 6
weeks can signiﬁcantly reduced mossy ﬁber sprouting, an
indicator for recurrent epilepsy. We further suggest that oral
u s eo fU Rc a np r o t e c th i p p o c a m p a ln e u r o n sf r o mc e l ld e a t h
by using NeuN immunostaining. Oral UR can also prevent
hippocampal neuronal death with reduced GFAP and S100B
proteins but GABAA receptors.
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